NCT00206232View on ClinicalTrials.gov

Novel Treatment for Diastolic Heart Failure in Women

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Heart Failure
Interventions
DRUG

Spironolactone

Research subjects are randomized to placebo versus spironolactone 25mg daily and followed for 6 months.

Trial Locations (1)

77030

Baylor College of Medicine Heart Clinic, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT00206232 - Novel Treatment for Diastolic Heart Failure in Women | Biotech Hunter | Biotech Hunter